Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Resveratrol Inhibits Myeloma Cell Growth, Prevents Osteoclast Formation, and Promotes Osteoblast Differentiation
2005
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly?
1993
An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene
1991
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Leukemia and the disruption of normal hematopoiesis
1991
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
1994 StandoutNature
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A
2005
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
2006 Standout
Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions
2009
Soft-Tissue Sarcomas in Adults
2005 Standout
Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis
2001 Standout
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
2004 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis
2010
BCL-2 family members and the mitochondria in apoptosis
1999 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Cytokine Expression in Multiple Myeloma and Monoclonal Gammopathy: Analysis by Reverse Transcription/Polymerase Chain Reaction and Quantitative PCR
1996
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
CSF-1 Receptor Signaling in Myeloid Cells
2014
Two Hundred Gastrointestinal Stromal Tumors
2000 Standout
PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene
2000 StandoutNobel
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Expression of glutathione s-transferasepi and sensitivity of human gastric cancer cells to cisplatin
1994
Molecular biology of erythropoietin
1993 StandoutNobel
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
c-Kit Point mutation in patients with myeloproliferative disorders
1997
Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: The diagnostic interface
2007
Diagnosis of gastrointestinal stromal tumors: A consensus approach
2002 Standout
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
1998 StandoutNobel
Extragastrointestinal (Soft Tissue) Stromal Tumors: An Analysis of 48 Cases with Emphasis on Histologic Predictors of Outcome
2000 Standout
Configuration of the TP53 Gene as an Independent Prognostic Parameter of Myelodysplastic Syndrome
2003
Mechanisms of Bone Metastasis
2004 Standout
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
The Biology of CSF-1 and Its Receptor
1992
The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I
1995 Standout
Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs
1999
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
The application of X‐chromosome gene probes to the diagnosis of myeloproliferative disease
1989
PVF2, a PDGF/VEGF‐like growth factor, induces hemocyte proliferation in Drosophila larvae
2002 StandoutNobel
Cytokine Network in Human Multiple Myeloma
1992
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
5 Myelodysplastic syndromes
1987
Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS- derived leukemia
1993
Mechanisms of Bone Lesions in Multiple Myeloma
1992
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
2006 StandoutNobel
Tyrosine Kinases as Targets for Cancer Therapy
2005
Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical Reversal
1996
Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.
1998 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.
1996 StandoutNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues.
1993
Biology of Gastrointestinal Stromal Tumors
2004 Standout
The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor.
1994
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
1998 StandoutScience
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease
2002
Glutathione S-transferase expression in benign and malignant ovarian tumours
1993
Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
1995
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines
1995
Hematopoietic growth factors and their receptors in acute leukemia
1993
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Growth Factors and Cancer
1991 StandoutScience
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Low-Dose 5-Aza-2′-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients
2000
Comparative Analysis of Mutant Tyrosine Kinase Chemical Rescue
2009 StandoutNobel
Altered Cytochrome c Display Precedes Apoptotic Cell Death in Drosophila
1999
Markedly Reduced Expression of Platelet c-mpl Receptor in Essential Thrombocythemia
1997
Works of A Jacobs being referenced
Glutathione-s-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data
1990
Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies
1991
Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein.
1991
Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.
1989
FMS mutations in myelodysplastic, leukemic, and normal subjects.
1990
Enrichment of progenitor cells from human marrow.
1987
Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
1986
A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group.
1994